Streptococcal diseases of group B, its screening efficiency and role in neonatal and gynecological practice
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20150403Keywords:
Obstetric, Group B streptococcus, Neonatal, New-born, Screening, Pregnancy, Prophylactic, Sepsis, Perinatal mortality, Latvia, RigaAbstract
Beta-haemolytic streptococcus of group B (BGS) is one of the main reasons for perinatal morbidity and mortality in developed countries. It is one of the key initiators of early sepsis and meningitis in new-born period. BGS is the cause of neonatal death for 1 new-born per 10 000. Prospectively maternity histories and new-born development histories of the Riga Maternity House in the period from 01.07.2013 to 31.12.2013 were analyzed. All in all 712 randomly selected records were examined, children born from 37th to 42nd week of pregnancy (median 39th week of pregnancy), with a birth weight of 2100 to 4880 grams, of which 373 were girls and 339 boys. The study included both neonates, whose mothers during pregnancy were screened for streptococcus of group B, and those, whose mothers were not screened, or the result was not known at the time of birth. The data were processed and statistically analyzed using programs MS Excel and SPSS Statistics 20. Results of SPSS Statistics 20 were compared using the chi-squared test. Out of 712 pregnant women viewed, who should have been screened according to national procedure, it was done and the result at the time of birth was known for 502 pregnant women (71%). Of 502 pregnant women who were screened, a positive result, which means that a woman was a BGS carrier, was confirmed in 87 cases (17%). Intrauterine infection of new-born, whose mothers were screened positive, was found in 15 cases (17%), and new-born, whose mothers were screened negative – in 24 cases or 6%. The only sepsis risk factor found in a study group was anhydrous childbirth period that is longer than 18 hours. The number of carriers of Group B streptococcus in Latvia coincides with the average number in the world. Although the number of antenatally unobserved pregnant women in Latvia is only around 2%, Group B streptococcus screening coverage of pregnant women is limited. Even when adequate prophylactic antibiotic therapy is received, it does not fully eliminate the possibility of intrauterine infection.
Metrics
References
Sarah S. Long, MD, Charles G. Prober, MD and Larry K. Pickering, MD, “Principles and Practice of Pediatric Infectious Diseases”, 4th Edition, Chapter 119: Streptococcus agalactiae (Group B Streptococcus)2012.708-713.
National Institute for Health and Clinical Excellence, Antibiotics for early-onset neonatal infection”, NICE clinical guideline 149, 2012. Available at: http://publications.nice.org.uk/antibiotics-for-early-onset-neonatal-infection-cg149 Accessed 16 Mart, 2014.
Robert M. Kliegman, MD, Bonita M.D. Stanton, MD, Joseph St. Geme, Nina Schor, MD, PhD and Richard E. Behrman, MD. “Nelson Textbook of Pediatrics”, 19th Edition, Chapter 177 – Group B Streptococcus, 925-928.
Jennifer R. Verani, MD, Lesley McGee, PhD Stephanie J. Schrag, Dphil “Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC, 2010” Morbidity and Mortality Weekly Report Recommendations and Reports, November 19, 2010.59/10.1-32.
Barcaite E, Bartusevicius A, Tameliene R. u.c. “Prevalence of maternal group B streptococcal colonization in European countries.” Department of Obstetrics and Gynaecology, Kaunas University of Medicine, Lithuania, 2008. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18307064 Accessed 18 April,2014.
M. J. Soto Marió, I Valenzuela, u.c. “Prevention of Early-onset Neonatal Group B Streptococcal Disease” Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3861949/#!po=12.5000 Accessed 1 April 2014.
Ann L Anderson-Berry, MD; Chief Editor: Ted Rosencrantz “Neonatal sepsis” 2012. Available at: http://emedicine.medscape.com/article/978352-overview#aw2aab6b2b3 Accessed 19 April 2014.
Tami H. Skoff, Monica M. Farley, Susan Petit “Increasing Burden of Invasive Group B Streptococcal Disease in Nonpregnant Adults, 1990–2007”, Clinical Infectious Diseases 2009. 49/1, 85–92.
Sagori Mukhopadhyay, Karen M. Puopolo „Risk Assessment in Neonatal Early-Onset Sepsis” [tiešsaiste], 2012 December. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782302/ Accessed 1 May 2014.
Committee on Infectious Diseases and Committee on Fetus and Newborn “Recommendations for the Prevention of Perinatal Group B Streptococcal (GBS) Disease”, PEDIATRICS, Official journal of the American Academy of Pediatrics, August 1, 2011,128/3,611-616.
National Institute for Health and Clinical Excellence, “Antibiotics for early-onset neonatal infection”, NICE clinical guideline 149,2012. Available at: http://publications.nice.org.uk/antibiotics-for-early-onset-neonatal-infection-cg149 Accessed 1 May 2014.
Anne Schuchat “Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms” 1998. Available at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC88893/#!po=5.43478 Accessed 7 July 2014.
Sarah S. Long, MD, Charles G. Prober, MD and Larry K. Pickering, MD „Principles and Practice of Pediatric Infectious Diseases”, 4th Edition, Chapter 119: Streptococcus agalactiae (Group B Streptococcus) 708-713.
Tami H. Skoff, Monica M. Farley, Susan Petit. Increasing Burden of Invasive Group B Streptococcal Disease in Nonpregnant Adults, 1990–2007. Clinical Infectious Diseases. 2009;49(1):85–92.
The Society of Obstetricians and Gynaecologists of Canada (SOGC) “The Prevention of Early-Onset Neonatal Group B Streptococcal Disease” 2013;298:1-10.
Morven S Edwards, MD „Clinical features and diagnosis of sepsis in term and late preterm infants” 2014. Available at: http://www.uptodate.com/contents/clinical-features-and-diagnosis-of-sepsis-in-term-and-late-preterm-infants. Accessed 3 May 2014.
Soman M, Green B, Daling J. “Risk factors for early neonatal sepsis”, 1985. Available at: http://www.ncbi.nlm.nih.gov/pubmed?term=4014163 Accessed 9 June 2014.
Karen M Puopolo, MD, PhD Carol J Baker, MD “Group B streptococcal infection in neonates and young infants” 2014. Available at: http://www.uptodate.com/contents/group-b-streptococcal-infection-in-neonates-and-young-infants. Accessed 15 June 2014.
Karen M Puopolo, MD, PhD Carol J Baker, MD “Management of the infant whose mother has received group B streptococcal chemoprophylaxis” 2014. Available at: http://www.uptodate.com/contents/management-of-the-infant-whose-mother-has-received-group-b-streptococcal-chemoprophylaxis. Accessed 10 July 2014.
